Paydirt
JC
Insider

Jon Congleton

Chief Executive Officer

Jon Congleton (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Mineralys Therapeutics, Inc. (MLYS). The largest single filing was $9.1M of MLYS (200,000 sh across 6 lots, as filed), executed Nov 11 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$14.8M
shares × price, as filed
Last traded
Jul 13
Filed Jul 15

Median ADV $38.0M across their filed names

Open performance
Volume by month
$9.1M$4.5M$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2024 · sells $206KJan 2025 · sells $166KApr 2025 · sells $187KJul 2025 · sells $230KOct 2025 · sells $578KNov 2025 · sells $9.1MJan 2026 · sells $530KApr 2026 · sells $2.4MJun 2026 · sells $2.0MJul 2026 · sells $291K
Buys $0 Sells $15.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names
MLYS Mineralys Therapeutics, Inc. MLYS · 0 buys · 11 sells 11 filings
Recent filings
MLYSSALE Mineralys Therapeutics, Inc. View filing → $291K
10,700 sh × $27.24
Exec Jul 13
Filed Jul 15 · 8:58 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $2.0M
75,000 sh across 2 lots
Exec Jun 30
Filed Jun 30 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $422K
15,730 sh × $26.83
Exec Apr 13
Filed Apr 15 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $2.0M
74,547 sh across 2 lots
Exec Mar 31
Filed Apr 2 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $530K
16,236 sh across 2 lots
Exec Jan 12
Filed Jan 13 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $9.1M
200,000 sh across 6 lots
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $578K
13,548 sh × $42.63
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET
MLYSSALE Mineralys Therapeutics, Inc. View filing → $230K
15,884 sh × $14.51
Exec Jul 11 2025
Filed Jul 15 2025 · 5:30 PM ET
More filings →